Surgical versus medical management of patients with primary hyperaldosteronism and indeterminate adrenal vein sampling: A 10-year experience of the Cleveland Clinic

IF 2.7 3区 医学 Q2 PERIPHERAL VASCULAR DISEASE
Chineme Onwubueke BS, Saif M Borgan MD, Huijun Xiao MS, Keren Zhou MD
{"title":"Surgical versus medical management of patients with primary hyperaldosteronism and indeterminate adrenal vein sampling: A 10-year experience of the Cleveland Clinic","authors":"Chineme Onwubueke BS,&nbsp;Saif M Borgan MD,&nbsp;Huijun Xiao MS,&nbsp;Keren Zhou MD","doi":"10.1111/jch.14810","DOIUrl":null,"url":null,"abstract":"<p>In patients with primary hyperaldosteronism (PA), adrenal vein sampling (AVS) can identify patients suitable for unilateral adrenalectomy. However, in AVS with an indeterminate aldosterone-to-cortisol lateralization (ACL) ratio of 3.0–4.0, clinical guidance is unclear. The authors screened all patients undergoing AVS at the Cleveland Clinic from October 2010 to January 2021 and identified 18 patients with indeterminate ACL results. Ten underwent adrenalectomy and eight continued medical management. The surgical group was younger (58.5 vs. 68 years, <i>p</i> = .17), and more likely to have a unilateral imaging adrenal abnormality (90% vs. 38%, <i>p</i> = .043) and a lower contralateral suppression index (0.63 vs. 1.1, <i>p</i> = .14). Post-treatment, the surgical group had a significant reduction in diastolic blood pressure (–5.5 mmHg, <i>p</i> = .043) and aldosterone (4.40 vs. 35.80 ng/mL, <i>p</i> = .035) and required fewer anti-hypertensive medications (2 vs. 3, <i>p</i> = .015). These findings may support the benefit of adrenalectomy in a select group of patients with indeterminate ACL.</p>","PeriodicalId":50237,"journal":{"name":"Journal of Clinical Hypertension","volume":null,"pages":null},"PeriodicalIF":2.7000,"publicationDate":"2024-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/jch.14810","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Clinical Hypertension","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/jch.14810","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
引用次数: 0

Abstract

In patients with primary hyperaldosteronism (PA), adrenal vein sampling (AVS) can identify patients suitable for unilateral adrenalectomy. However, in AVS with an indeterminate aldosterone-to-cortisol lateralization (ACL) ratio of 3.0–4.0, clinical guidance is unclear. The authors screened all patients undergoing AVS at the Cleveland Clinic from October 2010 to January 2021 and identified 18 patients with indeterminate ACL results. Ten underwent adrenalectomy and eight continued medical management. The surgical group was younger (58.5 vs. 68 years, p = .17), and more likely to have a unilateral imaging adrenal abnormality (90% vs. 38%, p = .043) and a lower contralateral suppression index (0.63 vs. 1.1, p = .14). Post-treatment, the surgical group had a significant reduction in diastolic blood pressure (–5.5 mmHg, p = .043) and aldosterone (4.40 vs. 35.80 ng/mL, p = .035) and required fewer anti-hypertensive medications (2 vs. 3, p = .015). These findings may support the benefit of adrenalectomy in a select group of patients with indeterminate ACL.

原发性高醛固酮症和肾上腺静脉取样不确定患者的手术治疗与药物治疗:克利夫兰诊所的十年经验
对于原发性高醛固酮血症(PA)患者,肾上腺静脉取样(AVS)可以确定哪些患者适合进行单侧肾上腺切除术。然而,对于醛固酮与皮质醇侧位比 (ACL) 为 3.0-4.0 的不确定 AVS 患者,临床指导尚不明确。作者筛选了 2010 年 10 月至 2021 年 1 月期间在克利夫兰诊所接受 AVS 的所有患者,确定了 18 名 ACL 结果不确定的患者。其中 10 人接受了肾上腺切除术,8 人继续接受药物治疗。手术组患者更年轻(58.5 岁对 68 岁,p = .17),更有可能出现单侧肾上腺影像异常(90% 对 38%,p = .043),对侧抑制指数更低(0.63 对 1.1,p = .14)。治疗后,手术组的舒张压(-5.5 mmHg,p = .043)和醛固酮(4.40 vs. 35.80 ng/mL,p = .035)显著下降,需要的抗高血压药物也减少了(2 vs. 3,p = .015)。这些研究结果可能支持肾上腺切除术对部分不确定 ACL 患者的益处。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Clinical Hypertension
Journal of Clinical Hypertension PERIPHERAL VASCULAR DISEASE-
CiteScore
5.80
自引率
7.10%
发文量
191
审稿时长
4-8 weeks
期刊介绍: The Journal of Clinical Hypertension is a peer-reviewed, monthly publication that serves internists, cardiologists, nephrologists, endocrinologists, hypertension specialists, primary care practitioners, pharmacists and all professionals interested in hypertension by providing objective, up-to-date information and practical recommendations on the full range of clinical aspects of hypertension. Commentaries and columns by experts in the field provide further insights into our original research articles as well as on major articles published elsewhere. Major guidelines for the management of hypertension are also an important feature of the Journal. Through its partnership with the World Hypertension League, JCH will include a new focus on hypertension and public health, including major policy issues, that features research and reviews related to disease characteristics and management at the population level.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信